The company has expanded its laboratories in the Virginia Biotechnology Research Park in Richmond, Virginia, by acquiring additional analytical capabilities, including advanced spectroscopy tools and ...

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio” or the "Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, ...

Zeit Aktuelle Nachrichten 11.04. BridgeBio Pharma, Inc.: BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE ...

Register for the Conference here. Submit Questions for any of the presenting compa Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen ...

Thursday, Piper Sandler reiterated an Overweight rating on BridgeBio Pharma (NASDAQ:BBIO) with a price target of $46.00, aligning with the broader Wall Street sentiment. According to InvestingPro data ...

Thursday, Piper Sandler reiterated an Overweight rating on BridgeBio Pharma (NASDAQ:BBIO) with a price target of $46.00, aligning with the broader Wall Street sentiment. According to InvestingPro ...

TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCI) on Wednesday reported a loss of $6.7 million in its fourth quarter. The Toronto-based company said it had a loss of $2.15 per share.

Shipping and logistics giant DHL Group is earmarking 2 billion euros ($2.2 billion) to bulk up its healthcare supply chain operations in order to meet growing demand from the biopharma industry.

For commercial teams, approval is the starting gun, not the finish line. Biopharma firms are now operating in a compressed commercial window. Pricing scrutiny is intensifying, regulatory environments ...

The facility also marks the debut of a new manufacturing execution system, replacing legacy systems and setting a template for other plants worldwide. Robotics for Safety and Inspection Novelis is ...